Overview

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
A phase III study to evaluate the efficacy and safety of SLIT for grass pollen allergens compared with placebo for reduction of symptoms and rescue medication usage in children.
Phase:
Phase 3
Details
Lead Sponsor:
Stallergenes
Stallergenes Greer